Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | PPP3CB | P16298 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.35 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7936992 | 0.94 | CTSB (0.48) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8242872 | 0.91 | CTSB (0.48) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL2215312 | 0.91 | CTSB (0.48) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL9978730 | 0.89 | CTSB (0.50) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL13385446 | 0.88 | CTSB (0.42) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL8250301 | 0.88 | CTSB (0.42) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL1688355 | 0.87 | CTSB (0.53) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL16021111 | 0.86 | CTSS (0.41) | CTSBPPP3CBCYP3A4ABCC1ABCC2 | |
| SCHEMBL17213007 | 0.84 | CTSB (0.37) | CTSBPPP3CBCTSS | |
| SCHEMBL9978732 | 0.83 | CTSB (0.48) | CTSBPPP3CBCYP3A4ABCC1ABCC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2937339-A1 | Macrocylic inhibitors of hepatitis c virus | Janssen Sciences Ireland UC (IE) | 2015-10-28 | — | — | EP | disclosed |